Literature DB >> 1690326

FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood.

J McCauley, A G Tzakis, J J Fung, S Todo, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1690326     DOI： 10.1016/0140-6736(90)90471-g

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  FK 506 and autoimmune disease: perspective and prospects.

Authors:  A W Thomson; T E Starzl
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

2.  FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome.

Authors:  J McCauley; R Shapiro; V Scantlebury; N Gilboa; M Jordan; C Jensen; A Naik; A Tzakis; D Ellis; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  The use of FK 506 in new-onset type I diabetes in man.

Authors:  P B Carroll; A G Tzakis; C Ricordi; H R Rilo; K Abu-Elmagd; N Murase; Y J Zeng; R Alejandro; D Mintz; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Treatment of Cogan's syndrome with FK 506: a case report.

Authors:  M I Roat; R A Thoft; A W Thomson; A Jain; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Use of FK 506 in pediatric patients.

Authors:  A G Tzakis; J J Fung; S Todo; J Reyes; M Green; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

6.  Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial.

Authors:  Li Fan; Qinghua Liu; Yunhua Liao; Zhibin Li; Yulian Ji; Zhenhua Yang; Jian Chen; Junzhou Fu; Jinli Zhang; Yaozhong Kong; Ping Fu; Tanqi Lou; Zhengrong Liu; Xueqing Yu; Wei Chen
Journal:  Int Urol Nephrol       Date:  2012-06-09       Impact factor: 2.370

7.  Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula.

Authors:  Eun Mi Yang; Sang Taek Lee; Hyun Jin Choi; Hee Yeon Cho; Joo Hoon Lee; Hee Gyung Kang; Young Seo Park; Hae Il Cheong; Il-Soo Ha
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

8.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

9.  Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome.

Authors:  J McCauley; R Shapiro; D Ellis; H Igdal; A Tzakis; T E Starzl
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

10.  Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome.

Authors:  Kim Loeffler; Manjula Gowrishankar; Verna Yiu
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.